University of Pisa   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Pisa Italy (1343)

Organization Overview

First Clinical Trial
1993
NCT00002896
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Antonio Barone | A.O.U. Pisana - P.O. di Cisanello | Azienda Ospedaliero Universitaria pisana | Azienda Ospedaliero, Universitaria Pisana | Azienda Ospedaliero Universitaria Pisana, Pisa Italy | Azienda Ospedaliero Universitaria Pisana, Pisa, Italy | Cardio-Thoracic and Vascular Dept, University of Pisa | Department of Clinical and Experimental Medicine, University of Pisa | Department of Obstetrics & Gynecology - University of Pisa | Department of Pediatrics, University of Pisa | Liver Transplantation Co-ordinating Section. Cisanello Hospital. (University of Pisa). | Oncologia Medica - Ospedale Santa Chiara Pisa | Oncology Department, Ospedale Santa Chiara, Trento | Ospedale Cisanello, Pisa | Ospedale Santa Chiara Pisa | Paola Anna Erba | Santa Chiara Hospital | Servizio di Fisiopatologia Respiratoria, Dipartimento Cardiotoracico, University of Pisa, Italy | Unit of Developmental Neurorehabilitation, Pisa University Hospital | Università di Pisa | Universita di Pisa, Italy | University Hospital Pisa, Italy | University of Pisa | University of Pisa Medical School Hospital, Pisa, Italy | University of Pisa, Pisa, Italy | University Pisa | U.O. Oncologia Medica 2 Universitaria - Azienda Ospedaliero-Universitaria Pisana Dipartimento di Ricerca Traslazionale e Nuove Tecnologie - Università di Pisa Istituto Toscano Tumori

Active Ingredients

Drugs in Phase 4 Trials (14)

abciximab (Reopro) (1 trial)

amoxicillin (1 trial)

atorvastatin (lipitor) (2 trials)

bifidobacterium longum (1 trial)

clavulanate (Augmentin) (1 trial)

dapagliflozin (farxiga) (2 trials)

hydrochlorothiazide (esidrix) (1 trial)

hypromelloses (1 trial)

lactoferrin (1 trial)

leuprolide (lupron) (1 trial)

methylprednisolone (medrol) (3 trials)

ozonated oil (1 trial)

sitagliptin (januvia) (2 trials)

triptorelin (Trelstar) (1 trial)

Drugs in Phase 3 Trials (26)

abiraterone (zytiga) (1 trial)

Asian spurge (1 trial)

beclomethasone (vanceril) (2 trials)

bevacizumab (avastin) (6 trials)

chf1535 (1 trial)

crizotinib (xalkori) (1 trial)

cyclophosphamide (cytoxan) (2 trials)

docetaxel (taxotere) (3 trials)

doxorubicin (Doxil) (2 trials)

enzalutamide (xtandi) (2 trials)

fluorouracil (efudex) (10 trials)

fluticasone (cutivate) (1 trial)

formoterol (foradil) (2 trials)

gemcitabine (gemzar) (2 trials)

glucose monohydrate (1 trial)

irinotecan (Camptosar) (9 trials)

leucovorin (8 trials)

methimazole (tapazole) (2 trials)

oxaliplatin (eloxatin) (9 trials)

panitumumab (vectibix) (1 trial)

pumpkin seeds (1 trial)

rituximab (rituxan) (1 trial)

salmeterol (serevent) (1 trial)

sargramostim (leukine) (1 trial)

somatropin (protropin) (1 trial)

thalidomide (Thalomid) (1 trial)

Drugs in Phase 2 Trials (26)

aciclovir (zovirax) (1 trial)

aldesleukin (proleukin) (1 trial)

baricitinib (olumiant) (1 trial)

capecitabine (xeloda) (2 trials)

COVID-19 convalescent plasma (1 trial)

decitabine (dacogen) (1 trial)

dexamethasone (1 trial)

empagliflozin (jardiance) (1 trial)

fluconazole (diflucan) (1 trial)

hepatitis b immune globulin (human) (BayHep B) (1 trial)

levofloxacin (levaquin) (1 trial)

polypepi1018 (1 trial)

prednisone (meticorten) (2 trials)

radretumab (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

saxagliptin (onglyza) (1 trial)

sirolimus (rapamune) (1 trial)

sorafenib (nexavar) (1 trial)

tipiracil (lonsurf) (1 trial)

tocilizumab (actemra) (1 trial)

topiramate (topamax) (1 trial)

tpi asm8 (1 trial)

trabectedin (yondelis) (1 trial)

triamcinolone (kenalog) (1 trial)

trifluridine (viroptic) (1 trial)

zinc dichloride (1 trial)

Drugs in Phase 1 Trials (2)

111in-cp04 (1 trial)

gelofusin (1 trial)

Drugs in Other Trials (6)

glucagon-like peptide-1 (1 trial)

imatinib (gleevec) (1 trial)

lactobacillus reuteri (1 trial)

lactobacillus rhamnosus (1 trial)

nilotinib (tasigna) (1 trial)

sélénium (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Brain Diseases (Phase 2)

Brain Ischemia (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Neuroendocrine (Phase 1)

Carcinoma, Renal Cell (Phase 2)

Cataract (Phase 4)

Chronic Disease (Phase 3)

Colitis (Phase 3)

Colitis, Ulcerative (Phase 3)

Colorectal Neoplasms (Phase 3)

Crohn Disease (Phase 3)

Diabetes, Gestational (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 2)

Disease (Phase 4)

Eye Diseases (Phase 4)

Eye Infections (Phase 4)

Fever (Phase 3)

Glomerulonephritis (Phase 3)

Glomerulonephritis, Membranous (Phase 3)

Glucose Metabolism Disorders (Phase 4)

Graves Ophthalmopathy (Phase 4)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis B (Phase 2)

Hepatitis B, Chronic (Phase 2)

Hypercholesterolemia (Phase 4)

Hypothermia (Phase 2)

Hypoxia (Phase 2)

Hypoxia-Ischemia, Brain (Phase 2)

Infarction (Phase 4)

Inflammatory Bowel Diseases (Phase 3)

Intestinal Diseases (Phase 3)

Ischemia (Phase 2)

Kidney Diseases (Phase 2)

Kidney Failure, Chronic (Phase 2)

Leiomyosarcoma (Phase 2)

Lung Diseases (Phase 2)

Lung Diseases, Obstructive (Phase 2)

Metabolic Diseases (Phase 4)

Multiple Myeloma (Phase 3)

Myocardial Infarction (Phase 4)

Neoplasm Metastasis (Phase 2)

Neoplasms, Plasma Cell (Phase 3)

Pancreatic Neoplasms (Phase 3)

Paresis (Phase 2)

Pelvic Pain (Phase 3)

Pneumonia (Phase 2)

Polycystic Ovary Syndrome (Phase 4)

Postoperative Complications (Phase 4)

Prediabetic State (Phase 2)

Premature Ejaculation (Phase 3)

Prostatic Neoplasms (Phase 3)

Prostatitis (Phase 3)

Puberty, Precocious (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Pulmonary Eosinophilia (Phase 3)

Rectal Neoplasms (Phase 3)

Recurrence (Phase 2)

Shoulder Pain (Phase 2)

Thyroid Diseases (Phase 1)

Thyroid Neoplasms (Phase 1)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 59
  • # of Trial APIs: 74